# An Atypical Presentation of Sporadic Creutzfeldt–Jakob Disease in the Setting of Chronic Alcohol Use Disorder

**Authors:** Coral Holt, Alia T. Sadek, Jordan Woodard, Rhett Grinstead

PMC · DOI: 10.1155/crnm/1332654 · Case Reports in Neurological Medicine · 2025-10-29

## TL;DR

A 60-year-old woman with alcohol use disorder showed symptoms resembling Wernicke encephalopathy but was diagnosed with sporadic CJD after MRI and CSF testing.

## Contribution

This case highlights the diagnostic challenge of CJD mimicking WE and emphasizes the importance of MRI in distinguishing these conditions.

## Key findings

- The patient lacked typical CJD features like myoclonus and abnormal EEG but had prominent aphasia and ataxia.
- MRI showed no lesions in WE-associated brain regions, aiding in the differential diagnosis.
- CSF testing and autopsy confirmed sporadic CJD despite initial suspicion of WE.

## Abstract

Sporadic Creutzfeldt–Jakob disease (CJD) is a rare but universally fatal condition with cardinal symptoms of rapidly progressive dementia and myoclonus. Wernicke encephalopathy (WE) is a reversible condition often presenting with the triad of altered mental status, ophthalmoplegia, and ataxia. Previous case reports have demonstrated overlap in the clinical features, imaging, and laboratory testing of CJD and WE. Here, we present the case of a 60-year-old female who presented with prominent aphasia and ataxia, lacking myoclonus and specific electroencephalogram (EEG) findings of CJD. Our patient's presentation was initially most suspicious for WE in the setting of alcohol use disorder, though maintaining a broad differential prompted extensive workup. Brain magnetic resonance imaging (MRI) was a key factor in distinguishing this case, as there were no lesions in the thalami, mammillary bodies, or periaqueductal gray matter, areas strongly associated with WE. Cerebrospinal fluid (CSF) testing for RT-QuIC, T-Tau protein and 14-3-3 GAMMA, and ultimately autopsy confirmed the diagnosis of sporadic CJD. We compare the clinical features, MRI, and EEG findings of our patient to those of similar cases, recognizing common areas of involvement that are also affected in WE. This case brings further attention to the variable presentation and clinical overlap of CJD with other neuropsychiatric diseases. We therefore endorse strong recommendations for maintaining a broad differential in patients presenting with nonspecific neurological complaints and promptly evaluating with MRI to better localize the affected areas.

## Linked entities

- **Proteins:** YWHAG (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma)
- **Diseases:** Creutzfeldt–Jakob disease (MONDO:0005357), Wernicke encephalopathy (MONDO:0007020)

## Full-text entities

- **Genes:** YWHAQ (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein theta) [NCBI Gene 10971] {aka 14-3-3, 1C5, HS1}
- **Diseases:** Sporadic Creutzfeldt-Jakob Disease (MESH:C565143), WE (MESH:D014899), myoclonus (MESH:D009207), aphasia (MESH:D001037), ophthalmoplegia (MESH:D009886), Chronic Alcohol Use Disorder (MESH:D000437), ataxia (MESH:D001259), neuropsychiatric diseases (MESH:D004194), CJD (MESH:D007562), dementia (MESH:D003704)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12588760/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12588760/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12588760/full.md

---
Source: https://tomesphere.com/paper/PMC12588760